Chemotherapy alone for patients 75 years and older with epithelial ovarian cancer - is interval cytoreductive surgery still needed?

D. A. Klein,A. Mann,A. Freeman,C. Liao,D. Kapp,J. Chan

Published 2020 in American Journal of Obstetrics and Gynecology

ABSTRACT

BACKGROUND Ovarian cancer patients ≥ 75 years old experience high peri-operative morbidity, but recruitment into prospective trials to assess the role of surgery continues to be challenging. OBJECTIVE To compare overall survival for ovarian cancer patients ≥75 years old after chemotherapy alone vs. neoadjuvant chemotherapy with interval cytoreductive surgery (NACT). STUDY DESIGN Data were extracted from the National Cancer Data Base from 2004 to 2014. Kaplan-Meier and Cox proportional hazards models were used for statistical analyses. RESULTS Of 1,661 patients (median age: 79 years), most were White (88%) and had stage III-IV disease (95%), and 51% had serous histology. Of those who did not receive primary surgery, 58% had chemotherapy alone and the remainder had NACT. The use of NACT increased from 28% to 50% in years 2004-2007 to 2012-2014 (p<0.001). Compared to NACT, chemotherapy only patients were older (80 vs. 78 years; p<0.001) and had more advanced stage disease (98% vs. 91%; p<0.001). The 5-year overall survival of the entire study group was 14%; those who underwent NACT had associated survival of 25% compared to only 7% in chemotherapy alone group (p<0.001). In multivariable analysis, NACT (HR=0.44, 95% CI: 0.36-0.54; p<0.001) was an independent predictor for improved survival. Older (80-84 years) age (HR=1.35, 95% CI: 1.12-1.63; p=0.002), advanced (stage III-IV) disease (HR=2.06, 95% CI: 1.37-3.09; p=0.001), and clear cell histology (HR=2.17, 95% CI: 1.10-4.28; p=0.03) portended for worse outcome. CONCLUSION Ovarian cancer patients ≥75 years old have an overall poor prognosis. Receiving neoadjuvant chemotherapy followed by interval cytoreductive surgery is associated with higher overall survival compared to chemotherapy alone.

PUBLICATION RECORD

CITATION MAP

EXTRACTION MAP

CLAIMS

  • No claims are published for this paper.

CONCEPTS

  • No concepts are published for this paper.

REFERENCES

Showing 1-34 of 34 references · Page 1 of 1